Rhythm Pharmaceuticals, Inc. (RYTM)
92.83
-0.58
(-0.62%)
USD |
NASDAQ |
Oct 02, 16:00
92.86
+0.02
(+0.03%)
After-Hours: 20:00
Rhythm Pharmaceuticals Profit Margin (Quarterly) : -69.19% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -69.19% |
| March 31, 2026 | -92.56% |
| December 31, 2025 | -82.97% |
| September 30, 2025 | -103.1% |
| June 30, 2025 | -96.14% |
| March 31, 2025 | -151.4% |
| December 31, 2024 | -103.5% |
| September 30, 2024 | -131.2% |
| June 30, 2024 | -110.9% |
| March 31, 2024 | -544.4% |
| December 31, 2023 | -171.7% |
| Date | Value |
|---|---|
| September 30, 2023 | -196.2% |
| June 30, 2023 | -243.0% |
| March 31, 2023 | -455.0% |
| December 31, 2022 | -483.4% |
| September 30, 2022 | -953.8% |
| June 30, 2022 | -496.4% |
| March 31, 2022 | -3.52K% |
| December 31, 2021 | -2.36K% |
| September 30, 2021 | -3.42K% |
| June 30, 2021 | -12.92K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 12.74% |
| BioMarin Pharmaceutical, Inc. | 4.49% |
| Cytokinetics, Inc. | -694.4% |
| Exelixis, Inc. | 33.73% |
| Ionis Pharmaceuticals, Inc. | -42.79% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -166.6% |
| Return on Assets | -45.83% |
| Return on Invested Capital | -59.85% |
| Gross Profit Margin (Quarterly) | 87.39% |
| Operating Margin (Quarterly) | -68.14% |
| Return on Net Operating Assets | -296.3% |